Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Use this ATXS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ATXS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ATXS SEC filings page. Lician reads the product cache first so this HTML stays unique to Astria Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ATXS income, balance, and cash tables.